The rise of copyright’s blockbuster initially sparked a boom for the drug industry, but recent shifts present a murky outlook for shareholders. Generic versions are eroding revenue, and continued legal battles add https://janaqziq188619.frewwebs.com/40203356/the-blue-pill-and-pharma-a-precarious-investment